Hc Advisors, LLC Bio N Tech Se Transaction History

Hc Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 07, 2021	SELL	$85.73 - $119.5 $349,092 - $486,604	-4,072 Closed	0 $0
Q4 2020 Feb 08, 2021	SELL	$72.71 - $129.54 $58,822 - $104,797	-809 Reduced 16.57%	4,072 $332,000
Q3 2020 Nov 04, 2020	SELL	$57.81 - $104.17 $152,329 - $274,487	-2,635 Reduced 35.06%	4,881 $338,000
Q2 2020 Aug 12, 2020	BUY	$38.58 - $66.74 $289,967 - $501,617	7,516 New	7,516 $502,000

357

38.3M

2.45M

2.29M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $27.4B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Hc Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Hc Advisors, LLC with notifications on news.